Please login to the form below

Not currently logged in

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities
UK flag

India-based pharma company Cipla has made inroads into the UK with a £100m investment in both research and commercial areas.

Cipla, which is best known for its pioneering role in providing HIV treatment to developing nations, intends to launch a range of drugs in respiratory, oncology and antiretroviral indications.

The company will also put money towards R&D, clinical trials and further expansion in the UK in what is a sign of confidence in the country's ability to attract pharma investment following downsizing by the likes of Pfizer and Novartis.

UK Chancellor of the Exchequer George Osborne said: “Cipla is one of India's leading pharmaceutical firms and this decision shows the UK's international strength and attractiveness in this sector as well as its growing importance in Cipla's long term strategy.”

Cipla's chief financial officer Rajesh Garg explained that the company was attracted by the strength of the UK's NHS and by recent government efforts to improve the research environment, including the Life Sciences Strategy.

“We are very pleased to be making this investment in the UK,” said Garg. “We were impressed with the pro-active support and engagement that the UK Government and its various ministries showed in attracting Cipla to choose the UK as a key hub in our global footprint.”

11th July 2014

From: Research, Sales, Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....